National Kidney Foundation's Primer on Kidney Diseases, Kartoniert / Broschiert
National Kidney Foundation's Primer on Kidney Diseases
Sie können den Titel schon jetzt bestellen. Versand an Sie erfolgt gleich nach Verfügbarkeit.
- Herausgeber:
- Scott F Gilbert, Daniel E Weiner, National Kidney Foundation
- Verlag:
- Elsevier Health Sciences, 12/2026
- Einband:
- Kartoniert / Broschiert
- Sprache:
- Englisch
- ISBN-13:
- 9780443261930
- Artikelnummer:
- 12851100
- Umfang:
- 688 Seiten
- Nummer der Auflage:
- 26009
- Ausgabe:
- 9th edition
- Gewicht:
- 449 g
- Erscheinungstermin:
- 1.12.2026
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Klappentext
Covering every relevant topic in this fast-changing field, National Kidney Foundation's Primer on Kidney Diseases, 9th Edition , remains your #1 source of practical, authoritative information in nephrology. Using a clear, concise, and accessible format, this bestselling guide provides well organized, highly readable guidance for residency, fellowship, clinical practice, and board review. The fully revised Primer brings you up to date with all that's new in the field , including ongoing clinical research and changing treatment protocols. Offering authoritative coverage of the full breadth of nephrology from world leaders in their field, this joint publication of Elsevier and the National Kidney Foundation is both an essential learning tool for trainees and an easy-to-use, reliable reference for practicing clinicians at the point of care.
- Provides clear, comprehensive coverage of every aspect of nephrology- from foundational science and clinical evaluation to glomerular disease, systemic disease, AKI, CKD, dialysis, transplantation, pediatrics, pregnancy, and hypertension
- Presents complex material in a clear, easy-to-understand manner that is both accessible to residents and fellows and comprehensive enough for practicing nephrologists
- Contains a new chapter on Critical Care Nephrology that equips clinicians with a practical, phenotypedriven approach to diagnosing and managing AKI in the ICU
- Covers major advances in treating glomerular diseases, including updated KDIGO guidelines and the rapid growth of precision therapies such as C3 inhibitors, BTK inhibitors, and podocytetargeted agents
- Includes new and expanded coverage of SGLT2 inhibitors, nonsteroidal MRAs, and GLP1 receptor agonists for kidney and cardiovascular protection in diabetic and nondiabetic CKD
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date